akhatri

The Department of Health and Social Care (DHSC) has issued a medicine supply notification for the following products: Levemir® (insulin detemir) FlexPen® 100units/ml solution for injection 3ml pre-filled pens Levemir® Penfill® 100units/ml solution for injection 3ml cartridges MSN/2025/036 Tier 2 – medium impact Date of issue: 16/06/2025 Levemir® (insulin detemir) FlexPen® 100units/ml solution for injection [...]

The post Medicine Supply Notification: Levemir® (insulin detemir) FlexPen® 100units/ml solution for injection 3ml pre-filled pens and Levemir® Penfill 100units/ml solution for injection 3ml cartridges appeared first on Community Pharmacy England.

MHRA Class 2 Medicines Notification: Inhixa 12,000IU (120mg)/0.8mL solution for injection (Maxearn Limited) Drug alert number: EL(25)A/27 Date issued: 12 June 2025 Maxearn Limited have informed the MHRA that the carton used to package two imported batches of Inhixa have been released to the market with a typographical error on one side of the carton. [...]

The post MHRA Class 2 Medicines Recall: Inhixa 12,000IU (120mg)/0.8mL solution for injection (Maxearn Limited) appeared first on Community Pharmacy England.

Community Pharmacy England would like to remind pharmacy owners of the requirement to submit their FP34C declaration using the Manage Your Service (MYS) portal and to dispatch any prescription bundles to the relevant pricing division at the NHS Business Services Authority (NHSBSA) no later than the 5th day of the month following that in which [...]

The post Reminder: Submit your FP34C declaration and prescription bundles on time appeared first on Community Pharmacy England.

Following representations from Community Pharmacy England, the Department of Health and Social Care (DHSC) has re-determined that the following products will be granted special container status from 1 June 2025. Generic drug name (dm+d descriptor) Brand and/or Manufacturer Pack size Special container Carmellose 1% eye drops 0.4ml unit dose preservative free Celluvisc® 1% eye drops [...]

The post 4 products re-classified as special containers from June 2025 appeared first on Community Pharmacy England.

MHRA Class 2 Medicines Notification: Mercaptopurine 50mg Tablets (Aspen Pharma Trading Limited) Drug alert number: EL(25)A/23 Date issued: 22 May 2025 Aspen Pharma Trading Limited is recalling a specific batch of Mercaptopurine 50mg tablets as a precautionary measure due to microbial contamination following a small number of complaints of discoloured tablets within the packs, identified [...]

The post MHRA Class 2 Medicines Recall: Mercaptopurine 50mg Tablets (Aspen Pharma Trading Limited) appeared first on Community Pharmacy England.